What is he best known for?
The fields of study he is best known for:
- Gene
- Biochemistry
- Receptor
His main research concerns Receptor, Neurotensin, Biochemistry, Neurotensin receptor and Pharmacology.
His Receptor study frequently draws parallels with other fields, such as Cell biology.
Jean Mazella interconnects Neuropil, Endocrinology and Zona incerta in the investigation of issues within Neurotensin.
His study in the field of Peptide, Residue and Tyrosine also crosses realms of Glycopeptide.
His Neurotensin receptor study incorporates themes from 5-HT5A receptor, Molecular biology, Peptide sequence and Neurotensin receptor 1.
His research integrates issues of Antidepressant, CREB, Neuron and Serotonin in his study of Pharmacology.
His most cited work include:
- Neurotensin and neurotensin receptors. (453 citations)
- The 100-kDa Neurotensin Receptor Is gp95/Sortilin, A Non-G-Protein-coupled Receptor (351 citations)
- Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. (204 citations)
What are the main themes of his work throughout his whole career to date?
Jean Mazella focuses on Receptor, Neurotensin, Neurotensin receptor, Biochemistry and Cell biology.
His Receptor research includes themes of Endocrinology, Intracellular and Pharmacology.
His Neurotensin study is associated with Neuropeptide.
In his research on the topic of Neurotensin receptor, Kinase, 5-HT5A receptor and Enzyme-linked receptor is strongly related with Molecular biology.
In the field of Biochemistry, his study on Tyrosine, Disuccinimidyl suberate and Dissociation constant overlaps with subjects such as Affinity chromatography and GTP'.
His biological study spans a wide range of topics, including Major depressive disorder and Antidepressant.
He most often published in these fields:
- Receptor (52.81%)
- Neurotensin (52.81%)
- Neurotensin receptor (31.46%)
What were the highlights of his more recent work (between 2016-2021)?
- Antidepressant (20.22%)
- Receptor (52.81%)
- Pharmacology (20.22%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Antidepressant, Receptor, Pharmacology, Cell biology and Neuroscience.
His Antidepressant research includes elements of Retro inverso, Biomarker, Stereochemistry and Major depressive disorder.
His research in Receptor is mostly focused on Neurotensin.
His work on Anti-inflammatory is typically connected to Stilbenoid as part of general Pharmacology study, connecting several disciplines of science.
His Cell biology research focuses on Potassium channel and how it relates to Cell and In vitro.
The concepts of his Neuroscience study are interwoven with issues in Fluoxetine, Monoamine neurotransmitter, Adverse effect and Protein–protein interaction.
Between 2016 and 2021, his most popular works were:
- Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity. (15 citations)
- Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients. (14 citations)
- Fighting against depression with TREK-1 blockers: Past and future. A focus on spadin. (10 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Amino acid
- Internal medicine
Jean Mazella mostly deals with Neuroscience, Depression, Antidepressant, Mood and Adverse effect.
He has included themes like Disease, Depolarization and Ion channel in his Neuroscience study.
Jean Mazella combines subjects such as Internal medicine, Pathophysiology, Cohort and Dosing with his study of Depression.
His Antidepressant study combines topics in areas such as HEK 293 cells, IC50, Endogeny and Pharmacology.
Jean Mazella has researched Mood in several fields, including Monoamine neurotransmitter, Fluoxetine and Mood disorders.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
